Busulmax 60mg Injection

Busulmax 60mg Injection is an antineoplastic chemotherapy agent belonging to the alkylating agent class, specifically an alkyl sulfonate. It is indicated for treating haematological malignancies, including chronic myelogenous leukaemia, a type of cancer characterised by increased white blood cell production in the bone marrow. Busulmax 60mg Injection is also used as conditioning therapy prior to allogeneic haematopoietic stem cell transplantation, where it prepares the bone marrow to receive healthy blood-forming stem cells from a donor to replace stem cells damaged by radiation or high-dose chemotherapy.

Chronic myelogenous leukaemia is an uncommon malignancy affecting the bone marrow, the soft spongy tissue responsible for producing blood cells, resulting in elevated white blood cell counts.

Common adverse effects include leucopaenia, dizziness, dyspnoea, oral mucositis, nausea, diarrhoea, insomnia, and fever. Maintain adequate fluid intake during treatment.

Busulmax 60mg Injection can cause severe bone marrow suppression. Patients taking concurrent prescribed or non-prescribed medications that reduce blood cell counts should consult their healthcare professional before initiating treatment. Busulfan affects immune function, increasing susceptibility to infection, including serious or potentially fatal infections. Contact your doctor if you develop fever, chills, cough, oral ulceration, or unexplained bleeding or bruising.

Hematopoietic progenitor cell transplantation Chronic myelogenous leukaemia Polycythaemia vera (type of cancer that causes increase in red blood cells) Thrombocythemia (increased number of platelets in the blood) Myelofibrosis (type of blood cancer where scar tissues are formed in bone marrow) Hemoglobinopathies (a genetic disorder that produces abnormal haemoglobin)

Bucelon works by interfering with the DNA replication process, which is necessary for the cells to divide. It stops tumor growth by inhibiting cell division. They cause cytotoxicity by reversibly binding to nucleophilic groups on different cell components. Alkylation of DNA is most likely the crucial cytotoxic reaction that kills tumor cells. It damages the DNA and RNA of the cancer cells by stopping their growth and multiplication. They are combined with other medications to treat various lymphatic and solid cancers.

Your physician will decide the dose and duration of this therapy. The dose of Busulfan depends on your blood cancer. Swallow the tablets with plenty of water. Do not break, crush or chew them. You can take busulfan tablets before or after meals. Don't stop the medication until or unless your doctor advises. If you missed the dose, do not take double the doses. Inform your physician about your missed dose.

Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them. Severe Myelosuppression (decreased bone marrow activity) Common side effects Thalassaemia Hair loss Patches of dark skin Blood in urine Decrease in the number of blood cells and platelets Nausea and vomiting Jaundice Infertility and sterility Pneumonia syndrome

Inform the doctor if the patient has taken radiotherapy priorly to the treatment. If you have other medical conditions like heart disease, lung, kidney, or liver problems. Tell your doctor if you have gout symptoms (pain and swollen joints caused by uric acid crystals).